Researchers Probe New Territory in Treating Patients with Lung Cancer during COVID-19 Pandemic

Press Briefing with International Researchers Explores this Question at IASLC 2020 World Conference on Lung Cancer SingaporeTo view a recording of the press briefing, visit:https://vimeo.com/506248459/caa7346336SINGAPORE, Jan. 29, 2021 (GLOBE NEWSWIRE) — On February 27, 2020, the flagship journal of the International Association for the Study of Lung Cancer, the Journal of Thoracic Oncology, published a case study that described two patients from Wuhan, China who recently underwent lung lobectomies for adenocarcinoma and were retrospectively found to have had COVID-19 at the time of surgery.Eleven months later, the lung cancer research community gathered virtually at the IASLC 2020 World Conference on Lung Cancer Singapore to share a number of research findings examining the intersection of COVID-19 and lung cancer. Researchers from a variety of countries participated in a press briefing to examine the connection between lung cancer and COVID-19.The press briefing was moderated by IASLC President-Elect Dr. Heather Wakelee, chief of the Division of Medical Oncology at Stanford University and deputy director of the Stanford Cancer Institute. Patient Advocate and lung cancer survivor Ivy Elkins, MBA, cofounder of the EGFR Resisters and a member of the IASLC Lung Cancer News (ILCN) Editorial Group, contributed insights from the advocacy community’s perspective.Earlier this…
Read More